Home › NDC Lookup › RxCUI directory › RxCUI 855170

Levocetirizine dihydrochloride 0.5 MG/ML Oral Solution [Xyzal] — RxCUI 855170

RxNorm drug concept · Semantic branded drug
RxCUI 855170 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI855170
Official nameLevocetirizine dihydrochloride 0.5 MG/ML Oral Solution [Xyzal]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asXyzal 0.5 MG/ML Oral Solution; XYZAL 2.5 MG in 5 mL 24HR Oral Solution; Xyzal 2.5 MG per 5 ML 24 HR Oral Solution
FDA products mapped4
Package NDCs mapped6
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Levocetirizine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's an antihistamine used to relieve the classic allergy symptoms — runny nose, sneezing, itchy and watery eyes, and itching of the nose or throat — caused by seasonal hay fever o...
  • What exactly is levocetirizine used for?
  • It can, yes — drowsiness is the most commonly reported side effect and it's more likely at higher doses. Many people tolerate it fine, but until you know how it affects you, it's s...
  • Yes, you can take it with or without food — either way works. If you take it with a high-fat meal, it may take a little longer to kick in and the peak level in your blood may be sl...
📖 Read our full Levocetirizine guide →

🕸️ Concept Web — How Levocetirizine dihydrochloride 0.5 MG/ML Oral So... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Levocetirizine dihydrochloride 0.5 MG/ML Oral Solution [Xyzal] RxCUI 855170

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Levocetirizine 356887
    • Levocetirizine dihydrochloride 402349
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Xyzal 398335
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Levocetirizine Oral Solution 759919
    • Levocetirizine dihydrochloride Oral Solution 2647466
    • Levocetirizine Oral Liquid Product 1163204
    • Levocetirizine Oral Product 1163205
    • Levocetirizine dihydrochloride Oral Liquid Product 2661627
    • Levocetirizine dihydrochloride Oral Product 2662910
    • Levocetirizine Oral Solution [Xyzal] 759922
    • Levocetirizine dihydrochloride Oral Solution [Xyzal] 2658185
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Levocetirizine dihydrochloride 0.5 MG/ML Oral Solution SCD · 855168
  • Levocetirizine dihydrochloride 0.5 MG/ML SCDC · 855167
  • Levocetirizine Oral Solution SCDF · 759919
  • Levocetirizine dihydrochloride Oral Solution SCDFP · 2647466
  • Levocetirizine Oral Liquid Product SCDG · 1163204
  • Levocetirizine Oral Product SCDG · 1163205
  • Levocetirizine dihydrochloride Oral Liquid Product SCDGP · 2661627
  • Levocetirizine dihydrochloride Oral Product SCDGP · 2662910

Brand-Name Concepts

  • Levocetirizine dihydrochloride 0.5 MG/ML [Xyzal] SBDC · 855169
  • Levocetirizine Oral Solution [Xyzal] SBDF · 759922
  • Levocetirizine dihydrochloride Oral Solution [Xyzal] SBDFP · 2658185
  • Xyzal Oral Liquid Product SBDG · 1186636
  • Xyzal Oral Product SBDG · 1186637
  • Xyzal BN · 398335

📦 FDA Products & Package NDCs

4 products · 6 package NDCs
6 package NDCs map to RxCUI 855170 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
41167-3533-00 1 BOTTLE in 1 CARTON (41167-3533-0) / 148 mL in 1 BOTTLE Childrens Xyzal Allergy Chattem, Inc. 2024-01-04
41167-3533-01 1 BOTTLE in 1 CARTON (41167-3533-1) / 295 mL in 1 BOTTLE Childrens Xyzal Allergy Chattem, Inc. 2026-01-01
41167-3535-00 1 BOTTLE in 1 CARTON (41167-3535-0) / 148 mL in 1 BOTTLE Childrens Xyzal Allergy Chattem, Inc. 2023-02-01
41167-3535-01 1 BOTTLE in 1 CARTON (41167-3535-1) / 296 mL in 1 BOTTLE Childrens Xyzal Allergy Chattem, Inc. 2023-04-01
41167-5803-09 90 TABLET, FILM COATED in 1 BOTTLE (41167-5803-9) Xyzal Chattem, Inc. 2017-07-24
41167-5804-05 1 BOTTLE in 1 CARTON (41167-5804-5) / 148 mL in 1 BOTTLE Xyzal Chattem, Inc. 2017-07-24
Observed labelers: Chattem, Inc. (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.